Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus

被引:69
作者
Silva, AP
Carvalho, AP
Carvalho, CM
Malva, JO [1 ]
机构
[1] Univ Coimbra, Dept Zool, Ctr Neurosci, P-3004517 Coimbra, Portugal
[2] Univ Coimbra, Fac Med, Biochem Lab, P-3004517 Coimbra, Portugal
关键词
glutamate release; hippocampus; intracellular calcium; Y1; receptors; Y2;
D O I
10.1046/j.1471-4159.2001.00560.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present work, we investigated the role of pre- and post-synaptic neuropeptide Y1 (NPY1) and Y2 receptors on the calcium responses and on glutamate release in the rat hippocampus. In cultured hippocampal neurones, we observed that only NPY1 receptors are involved, in the modulation of intracellular free calcium concentration ([Ca2+](i)). In 88% of the neurones analysed, the increase in the [Ca2+](i), in response to depolarization with 50 mm KCl, was inhibited by 1 muM [Leu31,Pro34]NPY, whereas 300 nM NPY13-36 was without effect. However, studies with hippocampal synaptosomes showed that both NPY1 and Y2 receptors can modulate the [Ca2+](i) and glutamate release. The pharmacological characterization of the NPY-induced inhibition of glutamate release indicated that Y2 receptors play a predominant role, both in the modulation of Ca2+-dependent and -independent glutamate release, However, we could distinguish between Y1 and Y2 receptors by using [Leu31,Pro34]NPY and NPY13-36. Active pre-synaptic Y1 receptors are present in the dentate gyrus (DG) as well as in the CA3 subregion, but its activity was not revealed by using the endogenous agonist, NPY. Concerning the Y2 receptors, they are present in the three subregions (CA1, CA3 and DG) and were activated by either NPY13-36 or NPY. The present data support a predominant role for NPY2 receptors in mediating NPY-induced inhibition of glutamate release in the hippocampus, but the physiological relevance of the presently described DG and CA3 presynaptic NPY1 receptors remains to be clarified.
引用
收藏
页码:286 / 296
页数:11
相关论文
共 51 条
[41]   Association of neuropeptide YY1 receptors with glutamate-positive and NPY-positive neurons in rat hippocampal cultures [J].
St-Pierre, JA ;
Nouel, D ;
Dumont, Y ;
Beaudet, A ;
Quirion, R .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (04) :1319-1330
[42]   Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurones and cloning of the rat Y2 receptor [J].
St-Pierre, JA ;
Dumont, Y ;
Nouel, D ;
Herzog, H ;
Hamel, E ;
Quirion, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (02) :183-194
[43]   Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites [J].
Statnick, MA ;
Schober, DA ;
Gackenheimer, S ;
Johnson, D ;
Beavers, L ;
Mayne, NG ;
Burnett, JP ;
Gadski, R ;
Gehlert, DR .
BRAIN RESEARCH, 1998, 810 (1-2) :16-26
[44]   MECHANISM OF PRESYNAPTIC INHIBITION BY NEUROPEPTIDE-Y AT SYMPATHETIC-NERVE TERMINALS [J].
TOTH, PT ;
BINDOKAS, VP ;
BLEAKMAN, D ;
COLMERS, WF ;
MILLER, RJ .
NATURE, 1993, 364 (6438) :635-639
[45]   MODULATION OF ANXIETY AND NEUROPEPTIDE-Y-Y1 RECEPTORS BY ANTISENSE OLIGODEOXYNUCLEOTIDES [J].
WAHLESTEDT, C ;
PICH, EM ;
KOOB, GF ;
YEE, F ;
HEILIG, M .
SCIENCE, 1993, 259 (5094) :528-531
[46]   NEUROPEPTIDE-Y RECEPTOR SUBTYPES [J].
WAN, CP ;
LAU, BHS .
LIFE SCIENCES, 1995, 56 (13) :1055-1064
[47]   Effects of the neuropeptide YY2 receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices [J].
Weiser, T ;
Wieland, HA ;
Doods, HN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 404 (1-2) :133-136
[48]   Neuropeptide Y inhibits glutamate release and long-term potentiation in rat dentate gyrus [J].
Whittaker, E ;
Vereker, E ;
Lynch, MA .
BRAIN RESEARCH, 1999, 827 (1-2) :229-233
[49]  
WIELAND HA, 1995, J PHARMACOL EXP THER, V275, P143
[50]   Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents [J].
Wieland, HA ;
Engel, W ;
Eberlein, W ;
Rudolf, K ;
Doods, HN .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (03) :549-555